Similar articles

• [Capecitabine-induced hyperpigmentation followed by hand-foot syndrome: a new case report].

  Agharbi FZ, Meziane M, Benhemmne H, Daoudi K, Elmesbahi O, Mikou O, Mernissi FZ. Agharbi FZ, et al. Ann Dermatol Venereol. 2012 Mar;139(3):221-2. doi: 10.1016/j.annder.2011.06.012. Epub 2012 Jan 14. Ann Dermatol Venereol. 2012. PMID: 22401689 French. No abstract available.
• Capecitabine-induced hand-foot syndrome and cutaneous hyperpigmentation in an elderly vitiligo patient.

  Tavares-Bello R. Tavares-Bello R. J Eur Acad Dermatol Venereol. 2007 Nov;21(10):1434-5. doi: 10.1111/j.1468-3083.2007.02242.x. J Eur Acad Dermatol Venereol. 2007. PMID: 17958867 No abstract available.
• Cutaneous drug Reactions: Chemotherapy-induced hyperpigmentation.

  Hernández-Aragüés I, Baniandrés-Rodríguez O, Vilas-Boas PT, Conde-Montero E, Suárez-Fernández R. Hernández-Aragüés I, et al. Eur J Dermatol. 2017 Dec 1;27(6):679-680. doi: 10.1684/ejd.2017.3180. Eur J Dermatol. 2017. PMID: 29311047 No abstract available.
• Sclerotic and retracted supravenous hyperpigmentation associated with combination chemotherapy for metastatic breast carcinoma.

  Chen GY, Lee JY, Chen WC. Chen GY, et al. Br J Dermatol. 2005 Jun;152(6):1383-5. doi: 10.1111/j.1365-2133.2005.06633.x. Br J Dermatol. 2005. PMID: 15949026 Review. No abstract available.
• Antineoplastic agent-associated serpentine supravenous hyperpigmentation: superficial venous system hyperpigmentation following intravenous chemotherapy.

  Geddes ER, Cohen PR. Geddes ER, et al. South Med J. 2010 Mar;103(3):231-5. doi: 10.1097/SMJ.0b013e3181ce0f5e. South Med J. 2010. PMID: 20134385 Review.